Navigation Links
Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
Date:6/10/2008

Phase 3 data highlight sustained efficacy and benefits of early treatment

with liraglutide versus glimepiride

SAN FRANCISCO, June 9 /PRNewswire-FirstCall/ -- Data presented today at the 68th Scientific Sessions of the American Diabetes Association (ADA) demonstrated that once-daily liraglutide when taken alone produced statistically significant improvement in blood sugar (glucose) control in patients with type 2 diabetes, as compared to glimepiride, a widely used oral anti-diabetic drug (OAD).

To view the Multimedia News Release, go to:

http://www.prnewswire.com/mnr/novonordisk/33424/

In addition, liraglutide demonstrated the following benefits compared to glimepiride:

-- Statistically significant reduction in body weight

-- Statistically significant reduction in risk of hypoglycemia

-- Statistically significant reduction in systolic blood pressure

In this 12-month study, 62% of patients treated with liraglutide who had not been previously treated with diabetes medications achieved an average reduction in blood sugar that brought them below the ADA target for HbA1c of 7%.

"This study showed that when used as initial drug treatment for type 2 diabetes, once-daily liraglutide not only statistically significantly reduced blood glucose, weight, and systolic blood pressure, but sustained blood glucose reductions for the duration of the study in patients who had never taken diabetes medications before," said study investigator Robert E. Ratner, MD, Vice President for Scientific Affairs at the MedStar Research Institute in Washington, DC. "The sustained reduction in blood glucose suggests that liraglutide may be beneficial when used earlier in the course of diabetes."

About the Study

The data presented today are from the LEAD(TM) 3 study, one of the five studies which make up the Phase 3 pro
'/>"/>

SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... SUNNYVALE,Calif.,Nov.23/PRNewswire-FirstCall/--Ac...efieldofradiosurgery,announcedtodaythatitsmanageme...ealthcareConferenceinNewYorkonTuesday,December1,20...tattheJ.P.MorganSmall/MidCapConferenceinNewYorkonT..., Alivewebcastofeachpresentationwillbeavailableo...
(Date:11/23/2009)... NORCROSS,Ga.,Nov.23/PRNewswire-FirstCall/--Immuco...matedinstrument-reagentsystemstothebloodtransfusio...natthePiperJaffray21stAnnualHealthCareConferencein...ast. ,, TheCompany,spresentationisscheduledforT...stothepresentationwillbeavailablethroughthe"AboutU...
(Date:11/23/2009)... CUPERTINO,Calif.,Nov.23/PRNewswire-FirstCall/--DU...ttHogan,ChiefFinancialOfficer,andJoeStauffer,Chief...rJaffrayHealthCareConferenceonTuesday,December1at3...orkPalaceHotelinNewYorkCity. ,, (Logo: http://w..., Toaccessthelivepresentationviatheinternet,plea...
Breaking Medicine Technology:Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference 2DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference 2GTSI to Spotlight Key Trends in Health IT at its June 17 Technology Leadership Series Seminar 47905 1GTSI to Spotlight Key Trends in Health IT at its June 17 Technology Leadership Series Seminar 47905 2GTSI to Spotlight Key Trends in Health IT at its June 17 Technology Leadership Series Seminar 47905 3Sigma Aldrich Honored With CIO 100 Award for Innovative Web Research Tool Your Favorite Gene powered by Ingenuity 12468 1Sigma Aldrich Honored With CIO 100 Award for Innovative Web Research Tool Your Favorite Gene powered by Ingenuity 12468 2Sigma Aldrich Honored With CIO 100 Award for Innovative Web Research Tool Your Favorite Gene powered by Ingenuity 12468 3Focused Health Solutions Helps Make Preventative Health Screenings Simple and More Affordable 47897 1Focused Health Solutions Helps Make Preventative Health Screenings Simple and More Affordable 47897 2Focused Health Solutions Helps Make Preventative Health Screenings Simple and More Affordable 47897 3
...e-FirstCall/ -- Pharmaxis,(ASX: PXS; Nasdaq: PXSL)...d,and Drug Administration (FDA) have reached agree...ol for bronchiectasis via the Special,Protocol Ass...evaluation of a clinical trial protocol,intended t...upport of a New,Drug Application, and provides an ...
..., a,leading global full-service clinical research ...f its experts will present at the upcoming Drug,In...he meeting is scheduled,for June 22-26, 2008, at t...on, Mass. Kendle,s experts will speak on key topic...EDC, biomarkers, regulatory affairs,adaptive clini...
Other Medicine Technology:Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 2Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 3Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 2Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 3
(Date:11/23/2009)...hildren who don,t access health care from the same...antly more likely to have unmet health care needs ...ublished in the journal Pediatrics . , Studies...and delivery of quality health care for children, ...y debates about health insurance reform, much of t...
(Date:11/23/2009)... patients who reined in their hypertension, study ...ews) -- High blood pressure is better controlled b...n by doctors and pharmacists working alone, a new ...acists, medications are intensified, dosages incre...ry L. Carter, a professor in the University of Iow...
(Date:11/23/2009)...ityBanksin Washington D.C. , NewYork , N.Y.... IntendedtoSpurEconomicGrowthandRevitalization ...Vita,thenation,sleadingproviderofdialysisservices,...ignedtocreatejobsandspurrevitalizationinminorityco...ommunityandminority-ownedbanks.DaVitahasdonated$5m...
(Date:11/23/2009)...Newswire/--CortivaInstituteTucsonwillhostanIntrodu...p.m.attheschool,s6390EastBroadwayBlvd.location,whi...dpracticebasicmassagestrokes. ,, "Massagetherap...rightalongwithit,"saidJoannMcMaster,presidentofCor...tofLabor,s2009-2010OccupationalOutlookHandbookstat...
(Date:11/23/2009)...breathing, protein may be the cause , , ...ers say they,ve identified a protein that causes ...t of people with chronic sinusitis. , The condi..., a constant irritation and swelling of the nasal ...tissue -- can block the sinus passages and make it...
Breaking Medicine News(10 mins):Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2Health News:Research Yields Clues to Severe Form of Sinusitis 2
...sider long, continuous workouts to be beneficial. ... may be a more effective way // to lower fat in th...tent exercises affect triglyceride levels. Triglyc...and did not exercise at all. On the second day, th...
...ed external defibrillators in public places can im...a heart attack.// Researchers randomly placed ... to normal during a heart attack -- in nearly 1,00...re then trained in either CPR alone or CPR plus th...
...ows Oppositional Defiant Disorder ( ODD ) may be t..., studied children // between ages 6 and 17 who we...ts were given a questionnaire and were further eva...en with migraines were more likely to have ODD tha...
...searchers a group of cells, called satellite cells...older people maintain // their youthfulness. These...ew muscle tissue. They also generate new cells for... Researchers found that young, middle-aged, and...
...prescribed to treat high blood pressure and other ...iabetes, may cause // angioedema, a condition char...y researchers based on findings of a recent study....ital with troublesome swelling of their lips and t...
...searchers the drug selegiline, also known as Eldep...th newly diagnosed Parkinson’s // disease. Sele...e oxidase type B inhibitors, which are used to slo...reased risk of death. However, selegiline did not ...
Other Medicine News:
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: